Contact lens and eye drop rewetter compositions and methods
3 Assignments
0 Petitions
Accused Products
Abstract
Stable ophthalmic formulations comprising hyaluronic acid (sodium hyaluronate) as the primary active demulcent ingredient, stabilized oxy-chloro complex (available commercially as OcuPure(tm) from Advanced Medical Optics, Purite® from Allergan, and Purogene from Biocide) for preservative efficacy, balanced salts mimicking the tear film, and sodium borate as a buffer are disclosed. In one embodiment, preferred stable formulations may be used in the human eye with or without contact lenses. In another embodiment preferred formulations may also be used as a storage and conditioning solution for contact lenses following disinfection.
26 Citations
133 Claims
-
1-102. -102. (canceled)
-
103. A stable ophthalmic composition which is comfortable to the human eye comprising:
-
about 0.1% to about 0.6% w/v hyaluronic acid; and
about 0.0020% to about 0.02% w/v stabilized oxy-chloro complex;
wherein said composition is surfactant-free. - View Dependent Claims (104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117)
-
-
118. A method of treating dry eye in a manner which is comfortable to the human eye comprising:
-
instilling a stable ophthalmic composition into the human eye;
wherein said stable ophthalmic composition comprises;
about 0.1% to about 0.6% w/v hyaluronic acid; and
about 0.0020% to about 0.02% w/v stabilized oxy-chloro complex;
wherein said composition is surfactant-free. - View Dependent Claims (119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133)
-
Specification